STAT Stitch Deep Dive Podcast Beyond The Bedside

STAT Stitch Deep Dive Podcast Beyond The Bedside

by Regular Guy
CoursesLife Sciences
Season 4

PEDI | Safety and Development of the Infant

Physical Growth and Vital Signs Infancy involves rapid physical maturation. Newborns may lose up to 10% of their birth weight but regain it by 10 to 14 days. Weight doubles by 4 to 6 months and triples by 1 year,. The posterior fontanel closes by 2 months, while the anterior closes by 12 to 18 months. Vital Signs by Age: • Heart Rate: Newborn (110–160/min); Infant (90–160/min). • Respirations: Newborn (30–60/min); Infant (25–60/min). • Blood Pressure (Average): Newborn (64/41 mm Hg); Infant (85/50 mm Hg). • Temperature: Ranges from 37.5°C (99.5°F) at 3 months to 37.7°C (99.9°F) at 1 year (axillary/rectal routes preferred). Pain Assessment: Nurses should use age-appropriate tools like the CRIES scale for neonates (assessing crying, oxygen requirement, vital signs, expression, and sleeplessness). For infants 2 months to 7 years, the FLACC scale (Face, Legs, Activity, Cry, Consolability) is used. Developmental Stages and Theories Development proceeds in a cephalocaudal (head-to-toe) and proximodistal (center-to-outward) pattern. For premature infants, developmental milestones and growth are assessed using their adjusted age (chronological age minus weeks premature),. • Psychosocial (Erikson): Trust vs. Mistrust. Caregivers must meet needs promptly to foster trust; delayed gratification is learned over time,. • Cognitive (Piaget): Sensorimotor Stage. Infants progress from reflexes to purposeful acts. Key achievements include Object Permanence (realizing objects exist when unseen, around 9 months) and mental representation,. Key Motor Milestones: • 2 Months: Holds head up when prone; social smile,. • 4 Months: Rolls from back to side; holds head steady; places objects in mouth,. • 6 Months: Rolls from back to front; sits with support (tripod); holds bottle,. • 9 Months: Sits unsupported; pulls to stand; uses crude pincer grasp,. • 12 Months: Walks with one hand held or cruises; sits from standing; uses fine pincer grasp,. Nutrition: Breast milk is the preferred complete nutrition for the first 6 months,. Vitamin D supplements are recommended immediately, and iron supplements may be needed after 4 months for exclusively breastfed infants. • Solids: Introduce at 6 months (starting with iron-fortified cereal). Introduce new foods every 3–5 days to identify allergies,. • Prohibited: No cow's milk or honey before 1 year. Sleep and Dental: Infants should sleep on a firm mattress in the supine (back) position to prevent SIDS,. Teething typically begins between 6 to 10 months; clean teeth with a cool, wet washcloth. Safety: • Car Seats: Rear-facing in the back seat at a 45-degree angle,. • Home: Cover outlets, use safety gates, set water heater <49°C, and avoid small choking hazards (grapes, coins, candy),. Immunization Schedule (0 to 12 Months) • Birth: Hepatitis B (Hep B). • 2 Months: DTaP, Rotavirus (RV), IPV (Polio), Hib, PCV (Pneumococcal), Hep B. • 4 Months: DTaP, RV, IPV, Hib, PCV. • 6 Months: DTaP, IPV, PCV, Hep B, RV, Hib. • 6 to 12 Months: Seasonal Influenza vaccination (yearly).
S4
Jan 23, 2026
27:59

PEDI | Safety and Development of the PreSchooler

Physical Growth and Vital Signs Preschoolers generally gain 4.5 to 6.5 lb (2 to 3 kg) and grow 2.5 to 3.5 inches (6.5 to 9 cm) per year. As they lose baby fat and gain muscle, they assume a more mature, sturdy posture. Neurologic myelination is typically complete by age 3, facilitating bowel and bladder control. For children ages 3 to 5, normal vital signs are: • Pulse: 70 to 120 beats per minute. • Respirations: 20 to 25 breaths per minute. • Temperature: Averages 37.2°C (99.0°F) at age 3, decreasing to 37.0°C (98.6°F) by age 5. • Blood Pressure: Systolic ranges from 89–98 mm Hg and diastolic from 46–53 mm Hg, depending on sex. • Pain Assessment: The FLACC scale is appropriate for ages 2 months to 7 years; however, children aged 3 and older can use self-report tools like the FACES scale or the Oucher photographic scale. Developmental Stages • Psychosocial (Erikson): This period is defined by "Initiative vs. Guilt," where children learn to plan activities, please parents, and develop a conscience. They may feel remorse when behaving badly. • Cognitive (Piaget): Preschoolers are in the preoperational stage, characterized by magical thinking (thoughts cause events), animism (lifelike qualities to inanimate objects), and egocentrism. • Motor Skills: ◦ Age 3: Rides a tricycle, goes up stairs with alternating feet, builds towers of 9-10 blocks, and undresses self. ◦ Age 4: Throws ball overhand, hops on one foot, uses scissors, and copies capital letters. ◦ Age 5: Skips, somersaults, prints some letters, ties shoelaces, and dresses independently. • Language: Vocabulary expands from 1,500 words at age 4 to 2,100 words by age 5. Children ask "why" and "when" questions and speak in sentences of 4 to 5 words by age 5. Health Promotion and Safety Preschoolers require 10 to 13 hours of sleep daily. Nightmares (remembered, child wakes up) differ from night terrors (child remains asleep, no memory of event). Nutritional needs include 700 to 1,000 mg of calcium and 7 to 10 mg of iron daily. Milk intake should be limited to 16 to 24 oz per day to prevent iron deficiency and obesity. Safety measures include using forward-facing car seats with a harness until outgrown, then a belt-positioning booster seat until a height of 145 cm is reached. Vaccination Schedule (Ages 4–6 Years) Routine immunizations for this age group focus on booster doses before entering school. The schedule includes: • DTaP (Diphtheria, tetanus, acellular pertussis): 5th dose recommended at ages 4–6 years. • IPV (Inactivated Poliovirus): 4th dose recommended at ages 4–6 years. • MMR (Measles, mumps, rubella): 2nd dose recommended at ages 4–6 years. • Varicella (Chickenpox): 2nd dose recommended at ages 4–6 years. • Influenza: 1 or 2 doses annually, depending on vaccination history. • COVID-19: Recommended based on current formulations and guidelines. For children who are behind schedule, catch-up guidance indicates that the 5th DTaP dose is not necessary if the 4th dose was administered at age 4 or older. Similarly, a 4th IPV dose is indicated if all previous doses were given before age 4
S4
Jan 23, 2026
30:13

PEDI | Safety and Development of the School Aged Kid

Growth and Development Physical Maturation School-age children experience slow, progressive growth, gaining an average of 2 to 3 kg (4–7 lb) and growing 5 to 7 cm (2–2.5 in) per year. The immune system reaches adult levels of immunoglobulins around age 10, respiratory rates decrease as breathing becomes diaphragmatic, and blood pressure increases while the pulse rate decreases. Developmental Stages • Psychosocial (Erikson): The primary task is Industry vs. Inferiority. Children develop a sense of self-worth by acquiring skills and succeeding in tasks at school and home. If expectations are too high or support is lacking, feelings of inferiority may develop,. • Cognitive (Piaget): Children enter the Concrete Operational stage (ages 7–11). They master the concept of conservation (understanding matter does not change when its form changes), learn to tell time, and engage in serial ordering, though they still lack abstract thinking,. • Moral (Kohlberg): This is the Conventional level. Younger school-age children (7–10) view behavior as "good" or "bad" based on consequences and pleasing others, while older children (10–12) respect "law and order" and the Golden Rule,. Social and Safety Concerns Peer relationships become vital, with a shift toward same-sex friend groups. Common concerns include bullying, screen time management, and obesity,. Safety education is critical, specifically regarding bicycle helmets, water safety, and car safety (using booster seats until the child is 4 feet 9 inches tall),. Vital Signs (School-Age: 6 to 12 Years) General guidelines for expected vital signs in this age group are: • Temperature: 36.7°C to 36.8°C (98.1°F to 98.2°F). • Pulse Rate: 60 to 110 beats/min. • Respirations: 20 to 25 breaths/min. • Blood Pressure (Average 50th Percentile): ◦ Males: 96/55 to 106/62 mm Hg. ◦ Females: 94/56 to 105/62 mm Hg. • Pain Assessment: For children 3 years and older, the FACES scale or Oucher photographic scale is appropriate. The Numeric scale (0–10) can be used for children 5 years and older who can verbally report pain levels. Vaccination Schedule The CDC recommends the following routine immunizations for this age group,,: • Ages 4–6 Years (School Entry): ◦ DTaP (Diphtheria, tetanus, and acellular pertussis): 5th dose. ◦ IPV (Inactivated poliovirus): 4th dose. ◦ MMR (Measles, mumps, rubella): 2nd dose. ◦ Varicella (Chickenpox): 2nd dose. • Ages 11–12 Years: ◦ Tdap (Tetanus, diphtheria, acellular pertussis): 1 adolescent booster dose,. ◦ MenACWY (Meningococcal serogroups A, C, W, Y): 1st dose,. ◦ HPV (Human papillomavirus): Routine vaccination recommended (2-dose series if started before age 15),. • Annual/Other: ◦ Influenza: 1 dose annually (or 2 doses if previously unvaccinated and under age 9),. ◦ COVID-19: Recommended per current CDC guidelines. ◦ Dengue: Recommended for ages 9–16 living in endemic areas with laboratory-confirmed previous infection
S4
Jan 23, 2026
24:38

PEDI | Safety and Development of the Teen

Based on the provided sources, the following is a summary focusing on the adolescent age group (11 to 20 years), covering their developmental milestones, vital signs, and immunization schedule. Adolescent Growth and Development Adolescence is defined as the transition from childhood to adulthood, spanning ages 11 to 20. This period is characterized by rapid physical, cognitive, and psychosocial changes. • Physiologic Changes: Puberty is driven by the hypothalamus releasing GnRH, stimulating the pituitary to release FSH and LH, which triggers gonadal response (estrogen in females, testosterone in males). Females generally enter puberty (ages 9–10) and reach physical maturity before males. A distinct growth spurt occurs, with females gaining 15–55 lbs and males gaining 15–65 lbs during this period. Organ systems mature, resulting in increased respiratory volume and blood volume, while the basal metabolic rate reaches adult levels. • Cognitive Development (Piaget): Adolescents enter the Formal Operations stage. Early adolescence involves limited abstract thought, while middle and late adolescence (14–20 years) see the development of abstract thinking, deductive reasoning, future planning, and the ability to think outside the present. • Psychosocial Development (Erikson): The primary task is Identity vs. Role Confusion. Adolescents strive to develop a sense of self and autonomy separate from parents. Peer groups become the essential source of support and identity validation, often leading to conflict with parents and a focus on conformity to peer norms. Vital Signs (Adolescents 13–18 Years) The expected physiological ranges for this age group approach adult values: • Temperature: Approximately 36.6° C (97.9° F) via oral, axillary, or tympanic routes. • Pulse Rate: 50 to 100 beats/minute. • Respirations: 16 to 20 breaths/minute. • Blood Pressure: Systolic less than 120 mmHg; Diastolic less than 80 mmHg. • Pain Assessment: The Numeric Scale (0–10) is the standard tool for self-reporting pain in children 5 years and older. The FACES scale (0–5 or 0–10) may also be used. Immunization Schedule (7–18 Years) The CDC recommends the following vaccines specifically for adolescents, assuming the childhood primary series was completed. Routine Vaccinations at 11–12 Years: • Tdap (Tetanus, diphtheria, and acellular pertussis): 1 dose is routinely administered at 11–12 years. • HPV (Human papillomavirus): Routinely recommended at 11–12 years (can start at age 9). If started before age 15, it is a 2-dose series (0, 6–12 months). If started at age 15 or older, it is a 3-dose series (0, 1–2, 6 months). • Meningococcal ACWY (MenACWY): 1st dose at 11–12 years, with a booster dose recommended at 16 years. Routine Annual Vaccination: • Influenza: 1 dose annually for all adolescents. Catch-up and Risk-Based Vaccinations: • Meningococcal Serogroup B (MenB): Recommended based on shared clinical decision-making for adolescents ages 16–23 (preferred 16–18 years), or for those at increased risk (e.g., asplenia). • Dengue: Recommended for ages 9–16 years living in endemic areas with laboratory confirmation of previous dengue infection. • Catch-up: Adolescents with incomplete histories should receive catch-up doses for Hepatitis B, Hepatitis A, Poliovirus (IPV), MMR, and Varicella. • COVID-19: Recommended per current schedule details
S4
Jan 23, 2026
24:56

PEDI | Cards C/ Drugs

Part 1: Pediatric Cardiovascular Health Fetal to Pediatric Transition The cardiovascular system begins developing by postconceptual day 17. Fetal circulation relies on shunts—the foramen ovale (atria connection) and ductus arteriosus (pulmonary artery to aorta connection)—to bypass the lungs, as oxygenation occurs via the placenta. Post-birth, these shunts close. Pediatric vitals differ significantly from adults: infants have higher heart rates (90–160 bpm) and lower blood pressure, both of which normalize toward adult levels by adolescence. Congenital Heart Disease (CHD) CHD constitutes the largest percentage of birth defects. Defects are categorized by their effect on blood flow: • Increased Pulmonary Flow: Includes Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA). These involve holes or connections that allow blood to flood the lungs. • Obstructive Disorders: Involve narrowing of vessels, such as Coarctation of the Aorta or valve stenosis, restricting blood flow. • Decreased Pulmonary Flow: The classic example is Tetralogy of Fallot, characterized by four defects (including VSD and overriding aorta) causing cyanosis. • Mixed Defects: Complex issues like Transposition of the Great Arteries, where the pulmonary artery and aorta are swapped. Acquired Heart Disease Heart failure is the most common reason for admission in acquired cases. Key conditions include: • Kawasaki Disease: An acute systemic vascular inflammation (leading cause of acquired heart disease) requiring IV immunoglobulin and aspirin. • Infective Endocarditis: Bacterial infection of heart valves, often requiring long-term antibiotics. • Rheumatic Fever: An autoimmune reaction to Group A strep pharyngeal infections, occurring 2–4 weeks post-infection. Core Nursing Management Care focuses on four pillars: improving oxygenation, promoting adequate nutrition (critical due to high metabolic demand), preventing infection, and supporting family coping. -------------------------------------------------------------------------------- Part 2: Pharmacology Spotlight — Propranolol Drug Class and Mechanism Propranolol is a non-selective beta-blocker (Class II anti-arrhythmic). It works by competing with catecholamines at receptor sites. It blocks beta-1 receptors (heart) to lower heart rate and blood pressure, and beta-2 receptors (lungs/vascular), which can inadvertently cause bronchospasm. Indications It is a versatile drug used for: • Cardiac: Hypertension, angina, and arrhythmias. • Non-Cardiac: Migraine prophylaxis, essential tremor, anxiety, and infantile hemangioma. Critical Safety Warnings • Boxed Warning: Do not abruptly discontinue. Stopping suddenly can exacerbate angina or precipitate myocardial infarction. Dosage must be tapered over at least 2 weeks. • Side Effects: Bradycardia, hypotension, bronchospasm (caution in asthmatics), and masking of hypoglycemia symptoms. Administration Guidelines • Oral: Immediate-release tablets should be taken with food. • Infantile Hemangioma (Hemangeol): Administer during or right after feeding to prevent hypoglycemia. Do not shake the bottle. Doses are given via oral syringe against the cheek.
S4
Feb 4, 2026
44:03

PEDI | Cards C/ NO DRUGS

Part 1: Pediatric Cardiovascular Health Fetal to Pediatric Transition The cardiovascular system begins developing by postconceptual day 17. Fetal circulation relies on shunts—the foramen ovale (atria connection) and ductus arteriosus (pulmonary artery to aorta connection)—to bypass the lungs, as oxygenation occurs via the placenta. Post-birth, these shunts close. Pediatric vitals differ significantly from adults: infants have higher heart rates (90–160 bpm) and lower blood pressure, both of which normalize toward adult levels by adolescence. Congenital Heart Disease (CHD) CHD constitutes the largest percentage of birth defects. Defects are categorized by their effect on blood flow: • Increased Pulmonary Flow: Includes Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA). These involve holes or connections that allow blood to flood the lungs. • Obstructive Disorders: Involve narrowing of vessels, such as Coarctation of the Aorta or valve stenosis, restricting blood flow. • Decreased Pulmonary Flow: The classic example is Tetralogy of Fallot, characterized by four defects (including VSD and overriding aorta) causing cyanosis. • Mixed Defects: Complex issues like Transposition of the Great Arteries, where the pulmonary artery and aorta are swapped. Acquired Heart Disease Heart failure is the most common reason for admission in acquired cases. Key conditions include: • Kawasaki Disease: An acute systemic vascular inflammation (leading cause of acquired heart disease) requiring IV immunoglobulin and aspirin. • Infective Endocarditis: Bacterial infection of heart valves, often requiring long-term antibiotics. • Rheumatic Fever: An autoimmune reaction to Group A strep pharyngeal infections, occurring 2–4 weeks post-infection. Core Nursing Management Care focuses on four pillars: improving oxygenation, promoting adequate nutrition (critical due to high metabolic demand), preventing infection, and supporting family coping. -------------------------------------------------------------------------------- Part 2: Pharmacology Spotlight — Propranolol Drug Class and Mechanism Propranolol is a non-selective beta-blocker (Class II anti-arrhythmic). It works by competing with catecholamines at receptor sites. It blocks beta-1 receptors (heart) to lower heart rate and blood pressure, and beta-2 receptors (lungs/vascular), which can inadvertently cause bronchospasm. Indications It is a versatile drug used for: • Cardiac: Hypertension, angina, and arrhythmias. • Non-Cardiac: Migraine prophylaxis, essential tremor, anxiety, and infantile hemangioma. Critical Safety Warnings • Boxed Warning: Do not abruptly discontinue. Stopping suddenly can exacerbate angina or precipitate myocardial infarction. Dosage must be tapered over at least 2 weeks. • Side Effects: Bradycardia, hypotension, bronchospasm (caution in asthmatics), and masking of hypoglycemia symptoms. Administration Guidelines • Oral: Immediate-release tablets should be taken with food. • Infantile Hemangioma (Hemangeol): Administer during or right after feeding to prevent hypoglycemia. Do not shake the bottle. Doses are given via oral syringe against the cheek.
S4
Feb 4, 2026
35:17

PEDI | Cards Pharmacology

Part 1: Pediatric Cardiovascular Health Fetal to Pediatric Transition The cardiovascular system begins developing by postconceptual day 17. Fetal circulation relies on shunts—the foramen ovale (atria connection) and ductus arteriosus (pulmonary artery to aorta connection)—to bypass the lungs, as oxygenation occurs via the placenta. Post-birth, these shunts close. Pediatric vitals differ significantly from adults: infants have higher heart rates (90–160 bpm) and lower blood pressure, both of which normalize toward adult levels by adolescence. Congenital Heart Disease (CHD) CHD constitutes the largest percentage of birth defects. Defects are categorized by their effect on blood flow: • Increased Pulmonary Flow: Includes Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA). These involve holes or connections that allow blood to flood the lungs. • Obstructive Disorders: Involve narrowing of vessels, such as Coarctation of the Aorta or valve stenosis, restricting blood flow. • Decreased Pulmonary Flow: The classic example is Tetralogy of Fallot, characterized by four defects (including VSD and overriding aorta) causing cyanosis. • Mixed Defects: Complex issues like Transposition of the Great Arteries, where the pulmonary artery and aorta are swapped. Acquired Heart Disease Heart failure is the most common reason for admission in acquired cases. Key conditions include: • Kawasaki Disease: An acute systemic vascular inflammation (leading cause of acquired heart disease) requiring IV immunoglobulin and aspirin. • Infective Endocarditis: Bacterial infection of heart valves, often requiring long-term antibiotics. • Rheumatic Fever: An autoimmune reaction to Group A strep pharyngeal infections, occurring 2–4 weeks post-infection. Core Nursing Management Care focuses on four pillars: improving oxygenation, promoting adequate nutrition (critical due to high metabolic demand), preventing infection, and supporting family coping. -------------------------------------------------------------------------------- Part 2: Pharmacology Spotlight — Propranolol Drug Class and Mechanism Propranolol is a non-selective beta-blocker (Class II anti-arrhythmic). It works by competing with catecholamines at receptor sites. It blocks beta-1 receptors (heart) to lower heart rate and blood pressure, and beta-2 receptors (lungs/vascular), which can inadvertently cause bronchospasm. Indications It is a versatile drug used for: • Cardiac: Hypertension, angina, and arrhythmias. • Non-Cardiac: Migraine prophylaxis, essential tremor, anxiety, and infantile hemangioma. Critical Safety Warnings • Boxed Warning: Do not abruptly discontinue. Stopping suddenly can exacerbate angina or precipitate myocardial infarction. Dosage must be tapered over at least 2 weeks. • Side Effects: Bradycardia, hypotension, bronchospasm (caution in asthmatics), and masking of hypoglycemia symptoms. Administration Guidelines • Oral: Immediate-release tablets should be taken with food. • Infantile Hemangioma (Hemangeol): Administer during or right after feeding to prevent hypoglycemia. Do not shake the bottle. Doses are given via oral syringe against the cheek.
S4
Feb 4, 2026
38:30

PEDI | Infection

Critical Bacterial & Toxin-Mediated Infections The most clinically significant bacterial infections require immediate recognition of airway compromise and strict adherence to antibiotic regimens. • Airway & Neurological Risks: ◦ Diphtheria: Caused by Corynebacterium diphtheriae, this presents with a "bull’s neck" (edema) and a pseudomembrane over the pharynx that can cause airway obstruction. Treatment involves antitoxins and antibiotics. ◦ Pertussis (Whooping Cough): Characterized by paroxysmal coughing and copious secretions, requiring careful airway management. ◦ Tetanus: Manifests as jaw cramping (lockjaw) and spasms. Prevention via immunization and wound cleaning is paramount; boosters may be required for injuries if more than 5 years have passed since the last dose. ◦ Botulism: A toxin-mediated infection causing generalized weakness, poor feeding, and a weak cry in infants, treated with Botulinum immune globulin. • Systemic & Soft Tissue Infections: ◦ Osteomyelitis: A bacterial bone infection (commonly S. aureus) presenting with fever, irritability, and tenderness. Management requires a long-term course (4–6 weeks) of antibiotics. ◦ Scarlet Fever: Resulting from Group A Strep, symptoms include high fever and a rash on the face and trunk. Droplet precautions are necessary. Vector-Borne & Parasitic Conditions Nurses must distinguish between self-limiting conditions and those requiring targeted medication to prevent complications. • Tick-Borne Diseases: ◦ Lyme Disease: Identified by a ring-like rash and joint pain. Without antibiotics (Doxycycline for children >8 years; Amoxicillin for <8 years), it can lead to neurological complications like cranial nerve palsy. ◦ Rocky Mountain Spotted Fever: Causes fever and rash; treated with Tetracycline. • Common Infestations: ◦ Pediculosis Capitis (Lice) & Scabies: Both cause intense pruritus (itching). Lice are treated with manual nit removal and permethrin, while scabies (mite lesions between digits) requires a scabicide left on for 8–14 hours. ◦ Pinworm: Characterized by anal itching and restlessness; diagnosed via a "tape test" and treated with anti-parasitics like mebendazole. Core Nursing Interventions (The Vital Few) The effectiveness of medical treatment relies heavily on supportive nursing care focused on prevention, comfort, and education. • Infection Control: Prevention is the first line of defense, including hand washing, adequate immunization, and proper food handling. • Symptom Management: ◦ Fever & Pain: Administer analgesics, encourage fluids, and dress febrile children in light clothing. Cool mist humidification aids respiratory comfort. ◦ Skin Integrity: Monitor rashes for infection. To prevent damage from scratching, keep fingernails short and apply antipruritics or cool compresses. • Patient Education: Teaching should be conducted in short sessions using multiple learning modes (visual, auditory). Nurses must assess the family's willingness to learn and provide reinforcement
S4
Feb 4, 2026
37:16

PEDI | Measles (rubeola)

Measles (rubeola) is an acute, highly contagious viral respiratory illness characterized by a distinct prodrome of fever and the "three Cs" (cough, coryza, and conjunctivitis), followed by a generalized rash. While indigenous transmission was declared eliminated in the U.S. in 2000, outbreaks continue to occur due to importation and unvaccinated populations. Clinical Presentation and Transmission • High Infectivity: The virus spreads via respiratory droplets and can remain airborne in closed areas for up to 2 hours. It is highly communicable, with a secondary attack rate of over 90% among susceptible contacts. • Contagious Period: Patients are contagious from 4 days before until 4 days after the rash appears. • Symptom Timeline: ◦ Incubation: Symptoms typically begin 7 to 14 days after exposure. ◦ Prodrome: Characterized by a stepwise fever rising to 103°F–105°F, cough, runny nose, and pink eye. ◦ Koplik Spots: Small blue-white spots on the inner cheek appear 1–2 days before the rash; these are considered unique to measles. ◦ Rash: A deep red, maculopapular rash begins at the hairline and spreads downward to the neck, torso, and extremities over 3 days. • Complications: Common complications include ear infections and diarrhea, while severe outcomes include pneumonia, encephalitis (brain inflammation), and death. Vaccination Protocols (MMR and MMRV) Prevention relies on the live, attenuated MMR (measles, mumps, rubella) or MMRV (+ varicella) vaccines. • Standard Schedule: Two doses are recommended for children: 1. Dose 1: Age 12 through 15 months. 2. Dose 2: Age 4 through 6 years (before school entry). • Efficacy: A single dose produces immunity in ~95% of children, while two doses provide >99% immunity, which is expected to be lifelong. • MMRV Precautions: For the first dose in children aged 12–47 months, administering separate MMR and Varicella vaccines is preferred over the combined MMRV shot, as MMRV carries a twofold higher risk of febrile seizures in this specific age group. • Adults and Travelers: Adults without evidence of immunity and international travelers (including infants 6–11 months) require vaccination, as measles remains endemic globally. Safety and Contraindications • Contraindications: Because it is a live vaccine, it must not be administered to pregnant women or individuals with severe immunocompromise (e.g., untreated HIV, leukemia, or high-dose steroid therapy). • Adverse Events: Common side effects include fever (5–15%) and a transient rash (5%) occurring 7–12 days post-vaccination. • Autism: Extensive studies and reviews by the National Academy of Medicine have refuted a causal relationship between the MMR vaccine and autism
S4
Feb 4, 2026
36:40

PEDI | Mumps

Mumps is an acute, contagious viral illness characterized by the swelling of salivary glands (parotitis). Historically a leading cause of aseptic meningitis and hearing loss in children, widespread vaccination has reduced cases by over 99%, though outbreaks continue to occur in close-contact settings. Clinical Presentation and Transmission • Symptoms: The hallmark symptom is parotitis (swelling of the parotid glands at the jaw), which lasts about 5 days. Prodromal symptoms are nonspecific, including low-grade fever, headache, myalgia (muscle pain), anorexia, and malaise. Approximately 15–24% of infections are asymptomatic. • Transmission: The virus spreads via respiratory droplets and saliva. • Contagiousness: Patients are infectious from 2 days before to 5 days after the onset of parotitis. It is considered as contagious as influenza but less so than measles. • Incubation: Symptoms typically appear 16 to 18 days after exposure. Complications While usually mild in children, mumps can cause serious complications, which are more common in adults and unvaccinated individuals. • Orchitis: The most common complication in post-pubertal males (inflammation of the testicles), occurring in up to 30% of unvaccinated men. It involves abrupt onset of pain and swelling and can lead to testicular atrophy. • Other Inflammations: Oophoritis (ovaries), mastitis (breasts), and pancreatitis. • Neurological: Meningitis and encephalitis occur but are rare (≤1%) in the post-vaccine era. • Hearing Loss: Sensorineural hearing loss can occur and may be permanent. Vaccination and Prevention Vaccination is the primary preventive measure. The U.S. uses the MMR (measles, mumps, rubella) or MMRV (includes varicella) vaccines, which contain live, attenuated virus. • Efficacy: One dose is approximately 78% effective; two doses are 88% effective. • Standard Schedule: ◦ Dose 1: Age 12–15 months. ◦ Dose 2: Age 4–6 years. • Contraindications: Pregnancy and severe immunocompromise are major contraindications. • Safety: The vaccine is safe. Fever and rash may occur. There is no causal link between the vaccine and autism. • Outbreaks: Since 2006, cases have risen, often in close-contact environments like colleges. During outbreaks, public health authorities may recommend a third dose of MMR for high-risk groups. Diagnosis and Management • Diagnosis: Clinical suspicion (parotitis) should be confirmed via RT-PCR (buccal or urine swab). Serology (IgM) is less reliable due to false negatives in vaccinated individuals. • Treatment: There is no specific antiviral treatment. Management is supportive care involving fluids, bed rest, and analgesics (acetaminophen or ibuprofen). Aspirin must be avoided in children due to the risk of Reye syndrome
S4
Feb 4, 2026
25:53
8 of 34